The AJH Visits FDA

Follow-Up Visits in Doctor-Patient Communication: The Vietnamese Case

In a “follow-up visit”, a patient seeks medical attention for an existing health problem. Using data from the Vietnamese public hospital system, we present a more nuanced analysis of follow-ups in health communication than the one currently available. To be specific, we discriminate between “same follow-ups”, in which the doctor is the same one as in the last visit, and “different follow-ups”, ...

AJH Educational Material Women Leaders in Hematology: Inspirations & Insights

Biography. Dr. Carol Kasper is a hematologist and Director Emeritus at the Orthopaedic Hemophilia Treatment Center in Los Angeles, California. Dr. Kasper is well known for her work on the diagnosis and treatment of hemophilia over the past 40 years. During her career, she has held numerous leadership positions within the field, including Vice President Medical of the World Federation of Hemophi...

23andMe and the FDA.

n engl j med 370;11 nejm.org march 13, 2014 985 of things about your health,” including that you “might have an increased risk of heart disease, arthritis, gallstones, [or] hemochromatosis” (www.ispot.tv/ad/7qoF/ 23-and-me). It was the centerpiece of the company’s campaign to sign up 1 million consumers. On November 22, the Food and Drug Administration (FDA) sent 23andMe a warning letter orderi...

The FDA and ECT.

The FDA and Cancer

Introduction C ancer is the second leading cause of death in the United States, exceeded only by heart disease, and it is the leading cause of death among those 35 to 64 years of age. One of every four deaths is from cancer. The federal government has spent more than $46 billion on cancer research since President Nixon declared a War on Cancer and Congress passed the National Cancer Act in 1971...